241 related articles for article (PubMed ID: 14524648)
1. Impact of atypical coverage for patients with community-acquired pneumonia managed on the medical ward: results from the United States Community-Acquired Pneumonia Project.
Frei CR; Koeller JM; Burgess DS; Talbert RL; Johnsrud MT
Pharmacotherapy; 2003 Sep; 23(9):1167-74. PubMed ID: 14524648
[TBL] [Abstract][Full Text] [Related]
2. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR
Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913
[TBL] [Abstract][Full Text] [Related]
3. Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy.
van Werkhoven CH; van de Garde EMW; Oosterheert JJ; Postma DF; Bonten MJM
Respir Med; 2017 Aug; 129():145-151. PubMed ID: 28732822
[TBL] [Abstract][Full Text] [Related]
4. Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.
Clark LC; Davis CW
Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S10-3. PubMed ID: 11098314
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals.
Dudas V; Hopefl A; Jacobs R; Guglielmo BJ
Ann Pharmacother; 2000 Apr; 34(4):446-52. PubMed ID: 10772428
[TBL] [Abstract][Full Text] [Related]
6. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
7. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
[TBL] [Abstract][Full Text] [Related]
8. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.
Brown RB; Iannini P; Gross P; Kunkel M
Chest; 2003 May; 123(5):1503-11. PubMed ID: 12740267
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
Izadi M; Dadsetan B; Najafi Z; Jafari S; Mazaheri E; Dadras O; Heidari H; SeyedAlinaghi S; Voltarelli F
Recent Pat Antiinfect Drug Discov; 2018; 13(3):228-239. PubMed ID: 30360748
[TBL] [Abstract][Full Text] [Related]
10. Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia.
Burgess DS; Lewis JS
Clin Ther; 2000 Jul; 22(7):872-8. PubMed ID: 10945513
[TBL] [Abstract][Full Text] [Related]
11. Total duration of antimicrobial therapy in veterans hospitalized with uncomplicated pneumonia: Results of a national medication utilization evaluation.
Madaras-Kelly KJ; Burk M; Caplinger C; Bohan JG; Neuhauser MM; Goetz MB; Zhang R; Cunningham FE;
J Hosp Med; 2016 Dec; 11(12):832-839. PubMed ID: 27527659
[TBL] [Abstract][Full Text] [Related]
12. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia.
Han X; Zhou F; Li H; Xing X; Chen L; Wang Y; Zhang C; Liu X; Suo L; Wang J; Yu G; Wang G; Yao X; Yu H; Wang L; Liu M; Xue C; Liu B; Zhu X; Li Y; Xiao Y; Cui X; Li L; Purdy JE; Cao B;
BMC Infect Dis; 2018 Apr; 18(1):192. PubMed ID: 29699493
[TBL] [Abstract][Full Text] [Related]
13. Initial empiric antibiotic therapy for community-acquired pneumonia in Chinese hospitals.
Nie XM; Li YS; Yang ZW; Wang H; Jin SY; Jiao Y; Metersky ML; Huang Y
Clin Microbiol Infect; 2018 Jun; 24(6):658.e1-658.e6. PubMed ID: 28970157
[TBL] [Abstract][Full Text] [Related]
14. Community-acquired pneumonia and do not resuscitate orders.
Marrie TJ; Fine MJ; Kapoor WN; Coley CM; Singer DE; Obrosky DS
J Am Geriatr Soc; 2002 Feb; 50(2):290-9. PubMed ID: 12028211
[TBL] [Abstract][Full Text] [Related]
15. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia.
Malone DC; Shaban HM
Ann Pharmacother; 2001 Oct; 35(10):1180-5. PubMed ID: 11675841
[TBL] [Abstract][Full Text] [Related]
16. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia.
Stahl JE; Barza M; DesJardin J; Martin R; Eckman MH
Arch Intern Med; 1999 Nov; 159(21):2576-80. PubMed ID: 10573047
[TBL] [Abstract][Full Text] [Related]
17. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
[TBL] [Abstract][Full Text] [Related]
18. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
[TBL] [Abstract][Full Text] [Related]
19. Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals.
Marras TK; Jamieson L; Chan CK
Can Respir J; 2004 Mar; 11(2):131-7. PubMed ID: 15045044
[TBL] [Abstract][Full Text] [Related]
20. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.
Shefet D; Robenshtock E; Paul M; Leibovici L
Cochrane Database Syst Rev; 2005 Apr; (2):CD004418. PubMed ID: 15846713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
